Evolent Health Stock Performance
| EVH Stock | USD 3.40 0.31 8.36% |
The firm shows a Beta (market volatility) of 0.59, which means possible diversification benefits within a given portfolio. As returns on the market increase, Evolent Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Evolent Health is expected to be smaller as well. At this point, Evolent Health has a negative expected return of -1.12%. Please make sure to confirm Evolent Health's value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Evolent Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Evolent Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Actual Historical Performance (%)
One Day Return (5.84) | Five Day Return (5.84) | Year To Date Return (4.63) | Ten Year Return (65.39) | All Time Return (80.33) |
1 | Evolent Health Misses Q3 Earnings Estimates | 11/06/2025 |
2 | Acquisition by Springstubb Brendan B of 10000 shares of Evolent Health at 3.8199 subject to Rule 16b-3 | 11/18/2025 |
3 | Insider Trading | 12/02/2025 |
4 | How the Narrative Surrounding Evolent Health Is Shifting After New Contracts and Softer Earnings Outlook | 12/10/2025 |
5 | Evolent Health Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in MedicareMedicaid Membership | 12/16/2025 |
6 | Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 | 01/02/2026 |
7 | Why Elevance Health Stock Is Trading Up Today | 01/08/2026 |
8 | Citizens Jmp Cuts Evolent Health Price Target to 10.00 | 01/09/2026 |
9 | Activity Recap Is Evolent Health Inc affected by consumer sentiment - July 2025 Analyst Calls Risk Controlled Daily Trade Plans - baoquankhu1.vn | 01/20/2026 |
10 | Q3 Earnings Highlights GoodRx Vs The Rest Of The Healthcare Technology Stocks | 01/26/2026 |
| Begin Period Cash Flow | 223.5 M | |
| Total Cashflows From Investing Activities | -62.9 M |
Evolent Health Relative Risk vs. Return Landscape
If you would invest 708.00 in Evolent Health on October 29, 2025 and sell it today you would lose (374.00) from holding Evolent Health or give up 52.82% of portfolio value over 90 days. Evolent Health is generating negative expected returns assuming volatility of 4.4907% on return distribution over 90 days investment horizon. In other words, 40% of stocks are less volatile than Evolent, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Evolent Health Target Price Odds to finish over Current Price
The tendency of Evolent Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.40 | 90 days | 3.40 | about 83.94 |
Based on a normal probability distribution, the odds of Evolent Health to move above the current price in 90 days from now is about 83.94 (This Evolent Health probability density function shows the probability of Evolent Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Evolent Health has a beta of 0.59 suggesting as returns on the market go up, Evolent Health average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Evolent Health will be expected to be much smaller as well. Additionally Evolent Health has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Evolent Health Price Density |
| Price |
Predictive Modules for Evolent Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evolent Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Evolent Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Evolent Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Evolent Health is not an exception. The market had few large corrections towards the Evolent Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Evolent Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Evolent Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.15 | |
β | Beta against Dow Jones | 0.59 | |
σ | Overall volatility | 1.28 | |
Ir | Information ratio | -0.27 |
Evolent Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Evolent Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Evolent Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Evolent Health generated a negative expected return over the last 90 days | |
| Evolent Health has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 2.55 B. Reported Net Loss for the year was (61.62 M) with profit before taxes, overhead, and interest of 378.34 M. | |
| Evolent Health has a strong financial position based on the latest SEC filings | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Q3 Earnings Highlights GoodRx Vs The Rest Of The Healthcare Technology Stocks |
Evolent Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Evolent Stock often depends not only on the future outlook of the current and potential Evolent Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evolent Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 114.7 M | |
| Cash And Short Term Investments | 163.5 M |
Evolent Health Fundamentals Growth
Evolent Stock prices reflect investors' perceptions of the future prospects and financial health of Evolent Health, and Evolent Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Evolent Stock performance.
| Return On Equity | -0.12 | ||||
| Return On Asset | 0.0012 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 1.41 B | ||||
| Shares Outstanding | 111.6 M | ||||
| Price To Earning | (13.88) X | ||||
| Price To Book | 0.52 X | ||||
| Price To Sales | 0.22 X | ||||
| Revenue | 2.55 B | ||||
| Gross Profit | 378.34 M | ||||
| EBITDA | 84.85 M | ||||
| Net Income | (61.62 M) | ||||
| Cash And Equivalents | 104.2 M | ||||
| Cash Per Share | 1.57 X | ||||
| Total Debt | 713.67 M | ||||
| Debt To Equity | 0.56 % | ||||
| Current Ratio | 1.03 X | ||||
| Book Value Per Share | 7.55 X | ||||
| Cash Flow From Operations | 18.77 M | ||||
| Earnings Per Share | (1.57) X | ||||
| Market Capitalization | 456.93 M | ||||
| Total Asset | 2.54 B | ||||
| Retained Earnings | (780.82 M) | ||||
| Working Capital | (108.38 M) | ||||
| Current Asset | 184.46 M | ||||
| Current Liabilities | 59.51 M | ||||
About Evolent Health Performance
By evaluating Evolent Health's fundamental ratios, stakeholders can gain valuable insights into Evolent Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Evolent Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Evolent Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 78.67 | 82.61 | |
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.07) | (0.07) |
Things to note about Evolent Health performance evaluation
Checking the ongoing alerts about Evolent Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Evolent Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Evolent Health generated a negative expected return over the last 90 days | |
| Evolent Health has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 2.55 B. Reported Net Loss for the year was (61.62 M) with profit before taxes, overhead, and interest of 378.34 M. | |
| Evolent Health has a strong financial position based on the latest SEC filings | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Q3 Earnings Highlights GoodRx Vs The Rest Of The Healthcare Technology Stocks |
- Analyzing Evolent Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Evolent Health's stock is overvalued or undervalued compared to its peers.
- Examining Evolent Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Evolent Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Evolent Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Evolent Health's stock. These opinions can provide insight into Evolent Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |